Sectors

BOLD
Boundless Bio, Inc.
2.81
2 x 2.09
2 x 3.60
bid
ask
-
0.02
0.71%
2 @ 07:07 PM
2.81 +0.00 (0.18%)
Ytd134.17%
1y150.89%
2.80
day range
2.94
0.96
52 week range
3.16
Open2.81Prev Close2.83Low2.80High2.94Mkt Cap63.92M
Vol103.24KAvg Vol1.28MEPS-2.85P/EN/AForward P/E-0.70
Beta-0.08Short Ratio2.01Inst. Own75.86%DividendN/ADiv YieldN/A
Ex Div DateN/AEarningN/A50-d Avg2.59200-d Avg1.601yr Est14.50
Income Statement
Operating Expenses24.38M
Research and Development Expense13.97M
Selling, General and Administrative Expense10.41M
Operating Income-24.38M
Net Income-23.69M
Net Income Common Stock-23.69M
Net Income Common Stock (USD)-23.69M
Consolidated Income-23.69M
Earnings per Basic Share-1.06
Earnings per Basic Share (USD)-1.06
Earnings per Diluted Share-1.06
Earning Before Interest & Taxes (EBIT)-23.69M
Earning Before Interest & Taxes (USD)-23.69M
Weighted Average Shares22.45M
Weighted Average Shares Diluted22.45M
Balance Sheet
Cash and Equivalents20.21M
Cash and Equivalents (USD)20.21M
Investments52.41M
Investments Current52.41M
Current Assets73.65M
Property, Plant & Equipment Net97.00K
Total Assets73.74M
Current Liabilities7.77M
Total Liabilities7.77M
Accumulated Retained Earnings (Deficit)-296.92M
Accumulated Other Comprehensive Income-32.00K
Shareholders Equity65.98M
Shareholders Equity (USD)65.98M
Assets Non-Current97.00K
Trade and Non-Trade Payables5.00M
Cash Flow
Depreciation, Amortization & Accretion7.49M
Net Cash Flow from Financing73.00K
Net Cash Flow / Change in Cash & Cash Equivalents2.17M
Capital Expenditure-38.00K
Issuance (Purchase) of Equity Shares73.00K
Net Cash Flow from Investing23.07M
Net Cash Flow - Investment Acquisitions and Disposals23.11M
Net Cash Flow from Operations-20.97M
Share Based Compensation3.22M